Shawn “Jay-Z” Carter’s cannabis brand is now public.
The Parent Company (OTCQX:GRAMF, NEO: GRAM.U)) a vertically integrated cannabis operator focused on the California market, completed its merger with Subversive Capital Acquisition Corp. (formerly traded on OTCQX under the symbol of SBVCF) in mid-January. The $1.2 billion deal is the largest cannabis deal ever involving a Special Purpose Acquisition Company, and makes The Parent Company the largest vertically integrated operator in the state.
The Parent Company is the product of the combination between cannabis brand Caliva (which launched the hip hop mogul’s high-end cannabis line MONOGRAM in December), extraction and manufacturer Left Coast Ventures, and Shawn Carter Enterprises.
ETFs were mostly in the red. Over the last five trading days:
The
The
The
The
The
Among the major news of the week was
Aleafia Health (TSX:AH) (OTCQX:ALEAF) partnership with trade union
Unifor – Canada’s largest private union, serving more than 300,000 members. The goal is to “support union members, retirees and their eligible dependents who receive medical cannabis insurance coverage through Unifor’s collective bargaining agreements.” Aleafia will serve union members and their families through its network of medical cannabis clinics, products, and scheduled same day delivery, according to Aleafia CEO Geoffrey Benic.
Benzinga Cannabis content is now available in Spanish on
Unifor.
The goal is to “support union members, retirees and their eligible dependents who receive medical cannabis insurance coverage through Unifor’s collective bargaining agreements.”
Unifor, Canada’s largest private union, has more than 300,000 members and represents workers at the big three automakers concentrated in Ontario.
Aleafia will serve union members and their families through its network of medical cannabis clinics, products, and scheduled same day delivery, according to Aleafia CEO Geoffrey Benic.
While patients currently pay out of pocket for medical cannabis, Benic says this is changing, as employers are now realizing the benefits of medical cannabis as an alternative to traditional pharmaceuticals.
Vertically integrated cannabis company
Aleafia Health Inc. (TSX:AH) (OTCQX:ALEAF) is expanding its global distribution network via a deal with Apipharm Veletrgovina d.o.o.
Aleafia agreed to supply the Europe-based pharmaceutical producer and distributor with dried cannabis flower under the three-year agreement.
The cannabis is cultivated at the company’s Niagara greenhouse facility.
According to a Friday press release, Apipharm Veletrgovina already ordered 1,000 kilograms of dried cannabis flower.
The Toronto-based company expects to ship the initial purchase order as early as the end of the first quarter of the current year.
Apipharm CEO Matevz Pompe said that teaming up with the Canadian cannabis supplier will “strengthen our market position in the development of advanced pharmaceutical formulations.”
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Aleafia Health Enters Definitive Supply Agreement with European Pharmaceutical Producer Apipharm
Aleafia Health Inc.January 8, 2021 GMT New international agreement strengthens Aleafia Health’s global distribution network
Initial purchase order for 1,000 kg of dried cannabis flower, with fulfilment of order underway
Apipharm a leading European natural pharmaceutical company with distribution in nine countries
TORONTO, Jan. 08, 2021 (GLOBE NEWSWIRE) Aleafia Health Inc. (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) has entered into a definitive three-year cannabis supply agreement (the “Supply Agreement”) with Apipharm Veletrgovina d.o.o. (“Apipharm”) a leading European pharmaceutical producer and distributor.